ASX Announcements

18-Apr-2024	Results of Meeting

8-Apr-2024	Application for quotation of securities - EXL

4-Apr-2024	Becoming a substantial holder

3-Apr-2024	Appendix 3Z - Ronald Dufficy

3-Apr-2024	Appendix 3X - Natalie Butler

3-Apr-2024	Appendix 3Y - David Fenlon

3-Apr-2024	Appendix 3Y - Ronald Dufficy

3-Apr-2024	Notification of cessation of securities - EXL

3-Apr-2024	Date of Annual General Meeting

28-Mar-2024	EOF: Sale of Ananda Food

28-Mar-2024	Completion of Ananda Food acquisition and Executive Changes

25-Mar-2024	Application for quotation of securities - EXL

22-Mar-2024	Security Class Reinstatement to Quotation

22-Mar-2024	Top 20 securityholders - Listed Options

22-Mar-2024	Application for quotation of securities - EXL

20-Mar-2024	Results of Fully Underwritten Rights Issue Offer

20-Mar-2024	Notice of Extraordinary General Meeting

18-Mar-2024	Security Class Suspension from Quotation

13-Mar-2024	Non-Renounceable Rights Issue Offer Closing Date Reminder

12-Mar-2024	Corporate Governance Statement and Appendix 4G

12-Mar-2024	FY23 Annual Report

7-Mar-2024	Mt Elephant Distribution

29-Feb-2024	FY23 Results Presentation

29-Feb-2024	FY23 Results Announcement

29-Feb-2024	FY23 Appendix 4E - Preliminary Final Report

26-Feb-2024	Dispatch of prospectus

20-Feb-2024	Binding Agreement to Divest Non-core Asset

19-Feb-2024	Optionholder Letter - Non-Renounceable Rights Issue Offer

19-Feb-2024	Prospectus - Non-Renounceable Rights Issue Offer

14-Feb-2024	Lifting of Trading Halt

14-Feb-2024	Update - Proposed issue of securities - EXL

14-Feb-2024	Substantial Interest in Entitlement Offer Shortfall

13-Feb-2024	Proposed issue of securities - EXL

12-Feb-2024	Ananda Food Acquisition and Capital Raising Presentation

12-Feb-2024	Ananda Food Acquisition and Proposed Capital Raising

12-Feb-2024	Sale of hemp food and animal products business

12-Feb-2024	Trading Halt

9-Feb-2024	Appendix 3Y - Ronald Dufficy

9-Feb-2024	Notification of cessation of securities - EXL

31-Jan-2024	Quarterly Activities/Appendix 4C Cash Flow Report

16-Jan-2024	Notification of cessation of securities - EXL

27-Nov-2023	Change of Phone Number

23-Nov-2023	Appendix 3Y - Ronald Dufficy

23-Nov-2023	Appendix 3Y - David Fenlon

23-Nov-2023	Cleansing Notice

23-Nov-2023	Notification regarding unquoted securities - EXL

23-Nov-2023	Application for quotation of securities - EXL

30-Oct-2023	Quarterly Update & Appendix 4C

25-Oct-2023	Investor Presentation October 2023

23-Oct-2023	Notification of cessation of securities - EXL

18-Oct-2023	Appendix 3Y - Pauline Gately

3-Oct-2023	Notification regarding unquoted securities - EXL

3-Oct-2023	Appendix 3Y - Ronald Dufficy

3-Oct-2023	Application for quotation of securities - EXL

3-Oct-2023	Appendix 3Z - Helen Wiseman

3-Oct-2023	Appendix 3Y - Helen Wiseman

3-Oct-2023	Notification of cessation of securities - EXL

2-Oct-2023	Director Resignation and Appointment of new Chair

4-Sep-2023	Appendix 3Y - Ronald Dufficy

4-Sep-2023	Appendix 3Y - David Fenlon

4-Sep-2023	Appendix 3Y - Helen Wiseman

1-Sep-2023	Cleansing Notice

31-Aug-2023	Notification regarding unquoted securities - EXL

31-Aug-2023	Application for quotation of securities - EXL

30-Aug-2023	H1 FY2023 Results Presentation

30-Aug-2023	H1 FY2023 Results Announcement

30-Aug-2023	H1 FY2023 Appendix 4D and Interim Report

23-Aug-2023	Ceasing to be a substantial holder

17-Aug-2023	Appendix 3X - Pauline Gately

17-Aug-2023	Notification regarding unquoted securities - EXL

17-Aug-2023	Application for quotation of securities - EXL

17-Aug-2023	Application for quotation of securities - EXL

17-Aug-2023	Implementation of Scheme of Arrangement with TSN

8-Aug-2023	Lodgement of Court Orders - Scheme becomes effective

8-Aug-2023	TSN: Lodgement of Court Orders - Scheme becomes effective

7-Aug-2023	Proposed issue of securities - EXL

7-Aug-2023	Court approves Scheme of Arrangement

7-Aug-2023	TSN: Court Approves Scheme

2-Aug-2023	TSN Results from Scheme Meeting

31-Jul-2023	Quarterly Activities/Appendix 4C Cash Flow Report

7-Jul-2023	Notification of cessation of securities - EXL

29-Jun-2023	Scheme Booklet registered with ASIC

29-Jun-2023	TSN: Scheme Booklet registered by ASIC

29-Jun-2023	TSN: Court orders convening of Scheme Meeting

29-Jun-2023	Update on Proposed Scheme of Arrangement

20-Jun-2023	TSN: Update on Scheme of Arrangement with EXL

20-Jun-2023	Update on Proposed Scheme of Arrangement

13-Jun-2023	Appendix 3Y - Ronald Dufficy

13-Jun-2023	Appendix 3Y - Helen Wiseman

8-Jun-2023	Notification regarding unquoted securities - EXL

7-Jun-2023	Correction to Directors Interest Notices

7-Jun-2023	Cleansing Notice

7-Jun-2023	Application for quotation of securities - EXL

7-Jun-2023	Application for quotation of securities - EXL

6-Jun-2023	Proposed issue of securities - EXL

5-Jun-2023	Appendix 3Y - Ronald Dufficy

1-Jun-2023	2023 AGM - AGM Recording

31-May-2023	Application for quotation of securities - EXL

31-May-2023	Appendix 3Y - Ronald Dufficy

31-May-2023	Appendix 3Y - David Fenlon

31-May-2023	Appendix 3Y - Helen Wiseman

31-May-2023	Notification regarding unquoted securities - EXL

31-May-2023	Notification regarding unquoted securities - EXL

31-May-2023	Amended Constitution

31-May-2023	2023 AGM - Voting Results

31-May-2023	2023 AGM - Chair's Address

31-May-2023	2023 AGM - CEO's Presentation

26-May-2023	Application for quotation of securities - EXL

24-May-2023	Completion of Underwritten Share Purchase Plan

23-May-2023	Company Secretary Appointment/Resignation

17-May-2023	TSN: Update on Scheme of Arrangement with EXL

17-May-2023	Update on Proposed Schemes of Arrangement

1-May-2023	Target Market Determination

1-May-2023	SPP BOOKLET AND OPTIONS PROSPECTUS

28-Apr-2023	Update - Proposed issue of securities - EXL

28-Apr-2023	Notice of Annual General Meeting

28-Apr-2023	SPP Underwriting Agreement

28-Apr-2023	Quarterly Update & Appendix 4C

27-Apr-2023	Application for quotation of securities - EXL

21-Apr-2023	TSN: Update on schemes of Arrangement with Elixinol

21-Apr-2023	Notification regarding unquoted securities - EXL

21-Apr-2023	Update - Schemes of Arrangement

20-Apr-2023	Proposed issue of securities - EXL

19-Apr-2023	Company Secretary Appointment/Resignation

14-Apr-2023	Correction to ASX Announcement - Cleansing Notice

14-Apr-2023	Application for quotation of securities - EXL

14-Apr-2023	Cleansing Notice

13-Apr-2023	Application for quotation of securities - EXL

6-Apr-2023	Appendix 3X - Ronald Dufficy

6-Apr-2023	Final Directors Interest Notice - Oliver Horn

6-Apr-2023	Final Directors Interest Notice - Paul Benhaim

6-Apr-2023	Notification of cessation of securities - EXL

6-Apr-2023	Board Changes

5-Apr-2023	TSN: Schemes of Arrangement Timetable Update

5-Apr-2023	Proposed issue of securities - EXL

5-Apr-2023	EXL Successfully Completes Placement & Launches SPP

3-Apr-2023	Trading Halt

24-Mar-2023	AGM Date Change

28-Feb-2023	AGM Date

28-Feb-2023	Appendix 3Y

28-Feb-2023	FY2022 Results Announcement

28-Feb-2023	Corporate Governance Statement and Appendix 4G

27-Feb-2023	FY2022 Appendix 4E and Annual Report

14-Feb-2023	Elixinol Wellness Successful in International Arbitration

31-Jan-2023	Quarterly Update and Appendix 4C

6-Jan-2023	Appendix 3Y - Helen Wiseman

6-Jan-2023	Appendix 3Y - Paul Benhaim

6-Jan-2023	Appendix 3Y - David Fenlon

6-Jan-2023	Appendix 3Y - Oliver Horn

6-Jan-2023	Notification of cessation of securities - EXL

30-Nov-2022	Ceasing to be a substantial holder

30-Nov-2022	Proposed issue of securities - EXL

29-Nov-2022	TSN: Schemes of Arrangement with Elixinol Wellness Ltd

29-Nov-2022	Proposed Acquisition of The Sustainable Nutrition Group Ltd

20-Oct-2022	Quarterly Update and Appendix 4C

5-Oct-2022	Notification of cessation of securities - EXL

29-Sep-2022	Change in substantial holding

30-Aug-2022	H1 FY2022 Results Presentation

30-Aug-2022	H1 FY2022 Results Announcement

30-Aug-2022	H1 FY2022 Appendix 4D and Interim Report

29-Jul-2022	Quarterly Update and Appendix 4C

27-Jul-2022	Change in substantial holding

8-Jul-2022	Notification of cessation of securities - EXL

7-Jun-2022	Change in substantial holding

27-May-2022	Notification regarding unquoted securities - EXL

26-May-2022	2022 AGM - Audio Recording

26-May-2022	2022 AGM - Voting Results

26-May-2022	2022 AGM - CEO Presentation

26-May-2022	2022 AGM Chairs Address

29-Apr-2022	Quarterly Update and Appendix 4C

22-Apr-2022	Notice of Annual General Meeting

4-Apr-2022	Appendix 3X - David Fenlon

28-Mar-2022	Strategic Review Update

1-Mar-2022	Application for quotation of securities - EXL

28-Feb-2022	AGM Date

25-Feb-2022	FY2021 Results Presentation

25-Feb-2022	FY2021 Results Announcement

25-Feb-2022	Corporate Governance Statement and Appendix 4G

25-Feb-2022	Annual Report

25-Feb-2022	FY2021 Appendix 4E

10-Feb-2022	Margin Loan Facility Concluded - Mr Banhaim

10-Feb-2022	Change in Substantial Holding - Paul Benhaim

31-Jan-2022	Quarterly Update and Appendix 4C

21-Jan-2022	Notification regarding unquoted securities - EXL

12-Jan-2022	Notification of cessation of securities - EXL

30-Dec-2021	Change in Substantial Holding - Paul Benhaim

30-Dec-2021	Appendix 3Y - Paul Benhaim

6-Dec-2021	Change in Substantial Holding - Paul Benhaim

6-Dec-2021	Appendix 3Y - Paul Benhaim

1-Nov-2021	Jobkeeper Payments Notice

22-Oct-2021	Appendix 2A

21-Oct-2021	Appendix 3Y - Oliver Horn

21-Oct-2021	Application for quotation of securities - EXL

19-Oct-2021	Appendix 3Y - Helen Wiseman

15-Oct-2021	Quarterly Update and Appendix 4C

13-Oct-2021	Notification of cessation of securities - EXL

1-Sep-2021	Application for quotation of securities - EXL

17-Aug-2021	H1 FY2021 Results Presentation

17-Aug-2021	H1 FY2021 Results Announcement

17-Aug-2021	H1 FY2021 Appendix 4D and Interim Report

22-Jul-2021	Quarterly Update & Appendix 4C

7-Jul-2021	Notification regarding unquoted securities - EXL

1-Jul-2021	EXL Presenting at ShareCafe Small Cap Hidden Gems Webinar

29-Jun-2021	Cancel - Proposed issue of securities - EXL

29-Jun-2021	Termination of Proposed CannaCare Health Acquisition

28-Jun-2021	Trading Halt

15-Jun-2021	EXL Presenting at Australian Micro & Small Cap Conference

9-Jun-2021	Distribution Expansion in Australian CBD Market

9-Jun-2021	HHI: Health House signs distribution agreement with Elixinol

1-Jun-2021	Appendix 2A

17-May-2021	Elixinol Changes its Name

17-May-2021	2021 AGM - Audio Recording

17-May-2021	2021 AGM - Voting Results

17-May-2021	2021 AGM - CEO Presentation

17-May-2021	2021 AGM - Chair's Address

27-Apr-2021	Investor Presentation

26-Apr-2021	Quarterly Update & Appendix 4C

15-Apr-2021	Notice of Annual General Meeting

25-Mar-2021	Positive Update on Novel Foods Application

18-Mar-2021	Investor Presentation Recording

16-Mar-2021	Investor Briefing & Investor Presentation

15-Mar-2021	AGM Date and Joint Company Secretary

15-Mar-2021	Proposed issue of Securities - EXL

15-Mar-2021	Reinstatement to Official Quotation

15-Mar-2021	Elixinol to Acquire 100% of CannaCare Health

8-Mar-2021	Suspension from Official Quotation

4-Mar-2021	Trading Halt

4-Mar-2021	Pause in Trading

3-Mar-2021	Appendix 2A

26-Feb-2021	Corporate Governance Statement and Appendix 4G

26-Feb-2021	FY2020 Results Announcement

26-Feb-2021	Annual Report

26-Feb-2021	FY2020 Appendix 4E

5-Feb-2021	Change in substantial holding

4-Feb-2021	Appendix 3Y - Oliver Horn

4-Feb-2021	Appendix 2A

27-Jan-2021	Quarterly Update & Appendix 4C

18-Jan-2021	Change in substantial holding

4-Jan-2021	Change in substantial holding

30-Dec-2020	Change in substantial holding

24-Dec-2020	Response to ASX Aware Query

21-Dec-2020	Change in Substantial Holding - Paul Benhaim

21-Dec-2020	Business Update

21-Dec-2020	Pet Releaf Supply Agreement Terminated

18-Dec-2020	Appendix 3Y - Oliver Horn

18-Dec-2020	Appendix 3Y - Helen Wiseman

18-Dec-2020	Appendix 2A

16-Dec-2020	Oversubscribed Share Purchase Plan

14-Dec-2020	Change in substantial holding

4-Dec-2020	Share Purchase Plan Update

3-Dec-2020	United Nations Reschedules Cannabis

30-Nov-2020	Change in substantial holding

24-Nov-2020	Becoming a substantial holder

23-Nov-2020	Change in Substantial Holding - Paul Benhaim

20-Nov-2020	Share Purchase Plan

20-Nov-2020	Appendix 2A

20-Nov-2020	Cleansing Statement

20-Nov-2020	Update - Proposed issue of Securities - EXL

19-Nov-2020	Response to ASX Query Letter

16-Nov-2020	Proposed issue of Securities - EXL

16-Nov-2020	Completion of Institutional Offer

13-Nov-2020	Trading Halt

13-Nov-2020	Change in Substantial Holding - Paul Benhaim

13-Nov-2020	Appendix 3Y - Paul Benhaim

13-Nov-2020	Appendix 3Y - Paul Benhaim

13-Nov-2020	Ceasing to be a Substantial Holder - D&G Health

13-Nov-2020	Change in Substantial Holding - D&G Health

10-Nov-2020	Response to ASX Price Query (updated)

10-Nov-2020	Response to ASX Price Query(updated)

9-Nov-2020	Response to ASX Price Query

29-Oct-2020	Investor Briefing Video Recording

27-Oct-2020	Investor Presentation

27-Oct-2020	Quarterly Update & Appendix 4C

27-Oct-2020	Correction to Appendix 3G

22-Oct-2020	Appendix 3G

22-Oct-2020	Revised Securities Trading Policy

30-Sep-2020	Appendix 3Y - Helen Wiseman

29-Sep-2020	Appendix 3Y - Oliver Horn

25-Sep-2020	Change of Share Registry

22-Sep-2020	Elixinol Trading Update

18-Sep-2020	Appendix 3Y - Paul Benhaim

18-Sep-2020	Appendix 3Y - Paul Benhaim

14-Sep-2020	H1 FY2020 Interim Report Announcement

14-Sep-2020	H1 FY2020 Interim Report

10-Sep-2020	Elixinol Appoints New Chair

31-Aug-2020	H1 FY2020 Results ASX Announcement

31-Aug-2020	H1 FY2020 Results Presentation

31-Aug-2020	H1 FY2020 Appendix 4D Preliminary Interim Report

4-Aug-2020	Quarterly Activities Report Addendum

31-Jul-2020	2020 AGM Audio Recording

30-Jul-2020	Appendix 3Y - Oliver Horn

30-Jul-2020	Appendix 3Y - Helen Wiseman

30-Jul-2020	Appendix 3G

30-Jul-2020	AGM RESULTS

30-Jul-2020	2020 AGM - CEO Presentation

30-Jul-2020	2020 AGM - Chairman's Address

30-Jul-2020	Quarterly Update & Appendix 4C

29-Jul-2020	Appointment of New Auditor

28-Jul-2020	EXL enters into exclusive License Agreement in Japan

27-Jul-2020	PharmaCann to Distribute Elixinol Products in Australia

30-Jun-2020	Notice of Annual General Meeting & Proxy Form

17-Jun-2020	Appendix 3Y - Paul Benhaim

11-Jun-2020	Notice of Annual General Meeting (AGM)

2-Jun-2020	D&G Health - Change of Substantial Holder

1-Jun-2020	Raw with Life - Change of Substantial Holder

1-Jun-2020	Appendix 2A

26-May-2020	EXL Successfully Completes Retail Entitlement Offer

25-May-2020	HFA Sale Termination

13-May-2020	Appendix 2A

12-May-2020	Despatch of Retail Entitlement Offer Booklet

12-May-2020	Notification to ineligible shareholders

11-May-2020	Class Action Dismissed

7-May-2020	Sale of Nunyara Land

6-May-2020	Completion of Institutional Offer

5-May-2020	Investor Conference Call Recording

5-May-2020	Cleansing Statement

5-May-2020	Appendix 3B

5-May-2020	Investor Presentation

5-May-2020	Elixinol Announces Capital Raising

30-Apr-2020	Quarterly Update & Appendix 4C

30-Apr-2020	Trading Halt

27-Apr-2020	Group CEO Update

27-Apr-2020	Appendix 3X - Helen Wiseman

27-Apr-2020	Appendix 3Z - Stratos Karousos

21-Apr-2020	Elixinol Global appoints new CEO and Strengthens Board

7-Apr-2020	Initial Director's Interest Notice for Mr Horn

7-Apr-2020	Final Director's Interest Notice for Mr Ellery

7-Apr-2020	Final Director's Interest Notice for Mr Duff

6-Apr-2020	Changes to the Board

30-Mar-2020	Global Rebrand & New Products

30-Mar-2020	Corporate Governance Statement and Appendix 4G

30-Mar-2020	Annual Report

27-Feb-2020	FY2019 Investor Results Presentation

27-Feb-2020	FY2019 Results ASX Announcement

27-Feb-2020	FY2019 Appendix 4E Preliminary Financial Report

6-Feb-2020	Response to ASX Appendix 4C Query Letter

3-Feb-2020	Sale of HFA and Nunyara Update

31-Jan-2020	Quarterly Update and Appendix 4C

21-Jan-2020	Response to ASX Price Query

14-Jan-2020	Appendix 3Y - Paul Benhaim

14-Jan-2020	Raw with Life - Change of Substantial Holder

8-Jan-2020	Appendix 2A - Release of Escrowed Securities

18-Dec-2019	Resignation of Chief Innovation Officer

18-Dec-2019	Mandatory Escrowed Securities to be Released

17-Dec-2019	Market Update

5-Dec-2019	Elixinols Comments on Potential Class Action

2-Dec-2019	Elixinol Japan Update

15-Nov-2019	Response to ASX Price Query

4-Nov-2019	Appointment of Global General Counsel and Company Secretary

29-Oct-2019	Quarterly Report and Appendix 4C

23-Oct-2019	Market Update Elixinol Japan Operations

21-Oct-2019	Trading Halt

21-Oct-2019	Pause in Trading

2-Oct-2019	Upcoming U.S. Investor Conferences

26-Sep-2019	Exclusive Distribution Agreement for Finland

23-Sep-2019	Appendix 3B

30-Aug-2019	Exclusive distribution agreement for Belgium & Luxembourg

29-Aug-2019	H1 FY2019 Results Presentation

29-Aug-2019	H1 FY2019 Results Announcement

29-Aug-2019	Appendix 4D and Interim Report

8-Aug-2019	Exclusive CBD supply agreement with Pet Releaf

30-Jul-2019	Quarterly Report and Appendix 4C

29-Jul-2019	Elixinol partners with PharmaCare

23-Jul-2019	Elixinol continues to build Leadership team

22-Jul-2019	Global IP rights for microencapsulation technology acquired

18-Jul-2019	Final Directors Interest Notice - Linda McLeod

18-Jul-2019	Initial Directors Interest Notice - Stratos Karousos

17-Jul-2019	Nunyara Manufacturing Licence

16-Jul-2019	Leadership and Group Structure update

4-Jul-2019	MedVec Distribution Agreement Signed

12-Jun-2019	D&G Health Change of Substantial Holder

12-Jun-2019	Raw with Life Change of Substantial Holder

12-Jun-2019	EXL Change of Substantial Holder

12-Jun-2019	Cleansing Statement and Appendix 3B

11-Jun-2019	Strategic Partnership with RFI

5-Jun-2019	Elixinol Global raises A$50m to accelerate US expansion

4-Jun-2019	Trading Halt

24-May-2019	Appendix 3B

24-May-2019	Final Directors Interest Notice

23-May-2019	AGM Results

23-May-2019	2019 AGM CEO Presentation

23-May-2019	2019 AGM Chairmans address

21-May-2019	Updated investor presentation May 2019

14-May-2019	EXL granted New York State CBD Authorization

13-May-2019	Investor Presentation May 2019

7-May-2019	Waiver from Listing Rule 14.7

24-Apr-2019	Cleansing Statement

24-Apr-2019	Appendix 3B

24-Apr-2019	Independent Valuation Report

24-Apr-2019	Elixinol acquires 25% of US based Pet Releaf

23-Apr-2019	Quarterly Report and Appendix 4C

18-Apr-2019	Notice of Annual General Meeting/Proxy Form

18-Apr-2019	Executive team expanded and Board change

18-Apr-2019	Initial Director's Interest Notice - Greg Ellery

12-Apr-2019	Appointment of Greg Ellery

28-Mar-2019	Corporate Governance Statement and Appendix 4G

28-Mar-2019	Annual Report

13-Mar-2019	Investor Update March/April 2019

11-Mar-2019	2019 Annual General Meeting

27-Feb-2019	Full Year Results Presentation Conference Call Recording

26-Feb-2019	FY 2018 Investor Results Presentation

26-Feb-2019	FY 2018 Results ASX Announcement

26-Feb-2019	FY 2018 Appendix 4E Preliminary Financial Report

21-Feb-2019	Elixinol FY2018 Results conference call

7-Feb-2019	Nunyara land purchase

5-Feb-2019	EXL expands into Europe driving international growth

31-Jan-2019	Quarterly Report and Appendix 4C

23-Jan-2019	Elixinol enters New Zealand market

8-Jan-2019	CFO relocation and appointment of Joint Company Secretary

27-Dec-2018	Appendix 3B - Release of Escrowed Securities

21-Dec-2018	2018 Farm Bill signed by the US President

13-Dec-2018	EXL Investor Newsletter

11-Dec-2018	Release of Restricted Securities

6-Nov-2018	Elixinol Global completes 50.5% investment in Elixinol Japan

5-Nov-2018	Raw with Life Change of Substantial Holder

5-Nov-2018	D&G Health Change of Substantial Holder

5-Nov-2018	EXL Change of Substantial Holder

1-Nov-2018	Appendix 3B

31-Oct-2018	EXL Sydney Wholesale Investor Presentation

30-Oct-2018	Quarterly Report and Appendix 4C

17-Oct-2018	EXL Aust Microcap Investment Conference Presentation

4-Oct-2018	Cleansing Statement and Appendix 3B

28-Sep-2018	Elixinol Global raises A$40m to accelerate international gro

26-Sep-2018	Trading Halt

24-Sep-2018	EXL increases ownership in Elixinol Japan

18-Sep-2018	EXL Commences Trading on OTCQX Market in United States

6-Sep-2018	EXL Presentation for Investor Briefings September 2018

30-Aug-2018	1H FY2018 Results Conference Call Recording

29-Aug-2018	1H 2018 Investor Results Presentation

29-Aug-2018	1H 2018 Results ASX Announcement

29-Aug-2018	Appendix 4D and 1H 2018 Interim Report

24-Aug-2018	Elixinol Global 1H FY2018 results conference call

30-Jul-2018	Quarterly Report and Appendix 4C

29-Jun-2018	Historic US Hemp Farming Legislation Passed

17-May-2018	Change of Director's Interest Notice - S Karousos

17-May-2018	Change of Director's Interest Notice - P Benhaim

17-May-2018	Change of Directors Interest Notice - L McLeod

17-May-2018	Change of Directors Interest Notice A Duff

15-May-2018	Appendix 3B

15-May-2018	2017 AGM Results

15-May-2018	2017 AGM Presentation

15-May-2018	2017 AGM Chairmans address

30-Apr-2018	Quarterly Report and Appendix 4C

24-Apr-2018	Elixinol enters into Joint Venture

12-Apr-2018	Notice of Annual General Meeting & Proxy Form

3-Apr-2018	Appendix 3B

28-Feb-2018	FY2017 Investor Results Presentation

28-Feb-2018	FY2017 Results ASX Announcement

28-Feb-2018	Corporate Governance Statement and Appendix 4G

28-Feb-2018	Appendix 4E and 2017 Annual Report

31-Jan-2018	Appendix 4C - quarterly

11-Jan-2018	Initial Director's Interest Notice - S Karousos

11-Jan-2018	Initial Director's Interest Notice - L McLeod

11-Jan-2018	Initial Director's Interest Notice - P Benhaim

11-Jan-2018	Initial Director's Interest Notice - A Duff

10-Jan-2018	Substantial Shareholder Notice - DG

10-Jan-2018	Substantial Shareholder Notice - RWL

10-Jan-2018	Substantial Shareholder Notice - Elixinol

8-Jan-2018	EXL begins trading on ASX

5-Jan-2018	ASX Market Release

5-Jan-2018	Pre-Quotation Disclosure Notice

5-Jan-2018	Corporate Governance Statement

5-Jan-2018	Securities Trading Policy

5-Jan-2018	Equity Plan Rules

5-Jan-2018	Hemp Foods Aust Pty Ltd Accounts FY 2015, 2016 and 2017

5-Jan-2018	Elixinol Pty Ltd Accounts HY 2017

5-Jan-2018	Elixinol Pty Ltd Accounts FY 2016

5-Jan-2018	Elixinol LLC Accounts FY 2015, 2016 and HY 2017

5-Jan-2018	Constitution

5-Jan-2018	Appendix 1A and Information Form and Checklist

5-Jan-2018	Top 20 Shareholders

5-Jan-2018	Distribution Schedule

5-Jan-2018	Prospectus

5-Jan-2018	ASX Market Release - Admission to Official List